PSN Extra
FDA recognizes The PSF-supported FACE-Q as a Medical Device Development Tool
By Paul Snyder Tuesday, May 3, 2022The FDA last week announced that it had accepted the FACE-Q as a qualified Medical Device Development Tool (MDDT) – a decision that not only provides the agency with patient perspective when it comes to evaluating new aesthetic treatments, but also national recognition for an idea that came into being thanks to The PSF's grant funding.
Remembering John Tebbetts, MD
By Steve Byrd, MD Monday, April 18, 2022Steve Byrd, MD, and fellow ASPS members pay tribute to John Tebbetts, MD, who passed away in March at age 75. Dr. Tebbetts is remembered as a "perfectionist in all things that he pursued."
Vote now on ASPS, PSF Bylaws and ASPS Code of Ethics amendments
Friday, April 1, 2022Active and Life Active ASPS members are encouraged to vote by May 31 on various amendments to the ASPS and PSF Bylaws and the ASPS Code of Ethics.
Remembering Michael Scheflan, MD, 1945-2022
By Paul Snyder Tuesday, February 22, 2022Plastic surgeons around the world are mourning the loss of Michael Scheflan, MD, past president of the Israel Society of Plastic Surgeons and a global leader in the specialty. Dr. Scheflan passed away on Feb. 12.
ASPS member is first plastic surgeon to win Kappa Delta Elizabeth Winston Lanier Award
By Paul Snyder Tuesday, February 15, 2022ASPS member L. Scott Levin, MD, FACS, made history in January as the first plastic surgeon to win the Kappa Delta Elizabeth Winston Lanier Award, which recognizes research in musculoskeletal disease or injury with great potential to advance patient care.
Medical start-ups invited to participate in MTI-ASPS plastic surgery track accelerator program
By Paul Snyder Tuesday, January 18, 2022Plastic surgeons positioned in the early or late (up to C-round funding) commercialization stages of creating a medical device, diagnostic or digital health company have the chance to become one of three Society-sponsored companies that will compete for up to $500,000 in prizes available through the MedTech Innovator ASPS plastic surgery track accelerator program.
ASPS supports lawsuit to stop regulatory overreach in No Surprises Act implementation
Thursday, January 13, 2022On Jan. 10, ASPS joined seven national medical societies, 16 state medical societies and the Physicians Advocacy Institute in filing an amicus curiae brief supporting the American Medical Association/American Hospital Association’s lawsuit challenging a key aspect of the 2020 federal out-of-network billing reform legislation, also known as the No Surprises Act (NSA).
Remembering ASPS past President Norman Cole, MD, 1936-2021
By Paul Snyder Monday, January 10, 2022Plastic surgeons are paying tribute to ASPS past President Norman Cole, MD, who passed away on Dec. 29. He was 85.
Breast implant checklist requirement: What you need to know
Tuesday, December 14, 2021The FDA recently issued new requirements for breast implant manufacturers to ensure patients are made aware of potential risks associated with the device. These requirements, however, include a stipulation that surgeons must provide, discuss and sign a patient-decision checklist during the informed-consent process.
Drawing up plans for the future
By Paul Snyder Monday, December 6, 2021The ASPS Board/EC Composition Task Force first convened in the fall of 2020 to identify opportunities for greater engagement on the part of the membership and significant stakeholders. The resulting task force recommendations led to the current plan for structural revisions to the ASPS/PSF Board of Directors.
